Table of Content

Executive Summary
Scope of Study

1. Global Alpha-1 Antitrypsin Deficiency Market: Market Outlook
1.1 Industry Outlook
1.1.1 Market Overview and Ecosystem
1.1.2 Market Trends
1.1.3 Epidemiological Analysis of Alpha-1 Antitrypsin Deficiency
1.1.3.1 By Region
1.1.4 Clinical Trials
1.1.4.1 By Phase
1.1.4.2 By Sponsor Type
1.1.5 Regulatory Landscape / Compliance
1.1.5.1 Legal Requirement and Framework in the U.S.
1.1.5.2 Legal Requirement and Framework in the E.U.
1.1.5.3 Legal Requirement and Framework in Japan
1.1.5.4 Legal Requirement and Framework in Rest-of-the-World
1.2 Market Dynamics
1.2.1 Impact Analysis
1.2.2 Market Drivers
1.2.3 Market Restraints
1.2.4 Market Opportunities

2. Global Alpha-1 Antitrypsin Deficiency Market, By Treatment, $Million, 2023-2035
2.1 Overview
2.2 Augmentation Therapy
2.3 Bronchodilators
2.4 Corticosteroids
2.5 Oxygen Therapy

3. Global Alpha-1 Antitrypsin Deficiency Market, By Distribution Channel, $Million, 2023-2035
3.1 Overview
3.2 Hospitals Pharmacy
3.3 Retail Pharmacies
3.4 Online Pharmacies

4. Global Alpha-1 Antitrypsin Deficiency Market, By Region, $Million, 2023-2035
4.1 North America
4.1.1 Key Findings
4.1.2 Market Dynamics
4.1.3 Market Sizing and Forecast
4.1.3.1 North America Alpha-1 Antitrypsin Deficiency Market (by Distribution Channel)
4.1.3.2 North America Alpha-1 Antitrypsin Deficiency Market (by Country)
4.1.3.2.1 U.S.
4.1.3.2.2 Canada
4.2 Europe
4.2.1 Key Findings
4.2.2 Market Dynamics
4.2.3 Market Sizing and Forecast
4.2.3.1 Europe Alpha-1 Antitrypsin Deficiency Market (by Distribution Channel)
4.2.3.2 Europe Alpha-1 Antitrypsin Deficiency Market (by Country)
4.2.3.2.1 U.K.
4.2.3.2.2 Germany
4.2.3.2.3 France
4.2.3.2.4 Italy
4.2.3.2.5 Spain
4.2.3.2.6 Rest of Europe
4.3 Asia-Pacific
4.3.1 Key Findings
4.3.2 Market Dynamics
4.3.3 Market Sizing and Forecast
4.3.3.1 Asia-Pacific Alpha-1 Antitrypsin Deficiency Market (by Distribution Channel)
4.3.3.2 Asia-Pacific Alpha-1 Antitrypsin Deficiency Market (by Country)
4.3.3.2.1 Japan
4.3.3.2.2 China
4.3.3.2.3 Rest of Asia-Pacific
4.4 Rest-of-the-World
4.4.1 Key Findings
4.4.2 Market Dynamics
4.4.3 Market Sizing and Forecast
4.4.3.1 Rest-of-the-World Alpha-1 Antitrypsin Deficiency Market (by Distribution Channel)

5. Global Alpha-1 Antitrypsin Deficiency Market - Competitive Landscape and Company Profiles
5.1 Competitive Landscape
5.1.1 Growth Share Matrix (2024)
5.1.1.1 By Treatment
5.1.2 Key Strategies and Developments by Company
5.1.2.1 Funding Activities
5.1.2.2 Mergers and Acquisitions
5.1.2.3 Regulatory Approvals
5.1.2.4 Partnerships, Collaborations and Business Expansions
5.1.3 Key Developments Analysis
5.2 Company Profiles
5.2.1 Grifols
5.2.1.1 Company Overview
5.2.1.2 Product Portfolio
5.2.1.3 Target Customers/End Users
5.2.1.4 Analyst View
5.2.2 CSL Behring
5.2.2.1 Company Overview
5.2.2.2 Product Portfolio
5.2.2.3 Target Customers/End Users
5.2.2.4 Analyst View
5.2.3 Takeda Pharmaceuticals
5.2.3.1 Company Overview
5.2.3.2 Product Portfolio
5.2.3.3 Target Customers/End Users
5.2.3.4 Analyst View
5.2.4 LFB Biotechnologies
5.2.4.1 Company Overview
5.2.4.2 Product Portfolio
5.2.4.3 Target Customers/End Users
5.2.4.4 Analyst View
5.2.5 GlaxoSmithKline plc
5.2.5.1 Company Overview
5.2.5.2 Product Portfolio
5.2.5.3 Target Customers/End Users
5.2.5.4 Analyst View
5.2.6 AstraZeneca
5.2.6.1 Company Overview
5.2.6.2 Product Portfolio
5.2.6.3 Target Customers/End Users
5.2.6.4 Analyst View
5.2.7 Merck
5.2.7.1 Company Overview
5.2.7.2 Product Portfolio
5.2.7.3 Target Customers/End Users
5.2.7.4 Analyst View
5.2.8 Pfizer Inc.
5.2.8.1 Company Overview
5.2.8.2 Product Portfolio
5.2.8.3 Target Customers/End Users
5.2.8.4 Analyst View

6. Research Methodology

List of Figures
Figure: Global Alpha-1 Antitrypsin Deficiency Market, Market Overview
Figure: Global Alpha-1 Antitrypsin Deficiency Market, Epidemiological Analysis, U.S.
Figure: Global Alpha-1 Antitrypsin Deficiency Market Coverage
Figure: Global Alpha-1 Antitrypsin Deficiency Market Key Trends, Impact Analysis, 2023-2035
Figure: Global Alpha-1 Antitrypsin Deficiency Market, Competitive Landscape, January 2022-April 2025

List of Tables
Table: Global Alpha-1 Antitrypsin Deficiency Market, Regulatory Scenario
Table: Global Alpha-1 Antitrypsin Deficiency Market Dynamics, Impact Analysis
Table: Global Alpha-1 Antitrypsin Deficiency Market (by Treatment), $Million, 2023-2035
Table: Global Alpha-1 Antitrypsin Deficiency Market (by Distribution Channel), $Million, 2023-2035